Endobronchial Ultrasound Biopsy Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: endobronchial-ultrasound-biopsy
Endobronchial Ultrasound Biopsy Market — USD 1.2 billion in 2023, Growing to USD 2.36B by 2033 at 6.8% CAGR
This report provides a comprehensive analysis of the Endobronchial Ultrasound Biopsy market from 2023 to 2033, highlighting market size, growth trends, regional insights, and key industry players. It aims to deliver data-driven insights for stakeholders making strategic decisions.
Key Takeaways
- Global market value increases from $1.20 Billion in 2023 to $2.36 Billion in 2033, reflecting a 6.8% CAGR for 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, expanding from $0.4 Billion in 2023 to $0.78 Billion in 2033.
- Europe and Asia Pacific show notable expansions: Europe from $0.32 Billion to $0.64 Billion, Asia Pacific from $0.25 Billion to $0.5 Billion.
- Top suppliers include Olympus Corporation, Boston Scientific Corporation, Medtronic, Fujifilm Holdings Corporation, and Conmed Corporation, driving device and needle innovations.
- Hospitals, diagnostic centers, and research institutes remain primary end users, with EBUS technology and EBUS needles central to clinical uptake.
Endobronchial Ultrasound Biopsy Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Endobronchial Ultrasound Biopsy market is projected to grow from $1.20 Billion in 2023 to $2.36 Billion by 2033 at a 6.8% CAGR for the 2023 to 2033 period. Growth is supported by rising demand for minimally invasive diagnostic tools, technological refinements in imaging and sampling devices, and increased clinical adoption across hospitals and diagnostic centers. North America is the largest regional market, while Europe, Asia Pacific, Latin America, and Middle East and Africa each show steady expansions. Key product categories include EBUS platforms and EBUS needles, and primary applications focus on lung cancer diagnosis and other pulmonary evaluations. Major companies such as Olympus Corporation, Boston Scientific Corporation, Medtronic, Fujifilm Holdings Corporation, and Conmed Corporation are active in product development and distribution. The report covers market sizing, segmentation by technology, application, and end user, regional breakdowns, and competitive positioning to inform strategic decisions and investment priorities.
Key Growth Drivers
- Rising need for accurate, minimally invasive diagnostics for pulmonary lesions and mediastinal staging.
- Technological improvements in ultrasound imaging and biopsy needle design enhancing diagnostic yield.
- Increasing procedural adoption within hospitals and diagnostic centers supported by clinician training.
- Growing investment by major device makers leading to wider product availability and clinical support.
- Heightened focus on early lung cancer detection driving demand for targeted biopsy techniques.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.20 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $2.36 Billion |
| Top Companies | Olympus Corporation, Boston Scientific Corporation, Medtronic , Fujifilm Holdings Corporation, Conmed Corporation |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
Endobronchial Ultrasound Biopsy Market Overview
Customize Endobronchial Ultrasound Biopsy Market Report market research report
- ✔ Get in-depth analysis of Endobronchial Ultrasound Biopsy market size, growth, and forecasts.
- ✔ Understand Endobronchial Ultrasound Biopsy's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Endobronchial Ultrasound Biopsy
What is the Market Size & CAGR of Endobronchial Ultrasound Biopsy Market Report market in 2023?
Endobronchial Ultrasound Biopsy Industry Analysis
Endobronchial Ultrasound Biopsy Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Endobronchial Ultrasound Biopsy Market Report Market Analysis Report by Region
Europe Endobronchial Ultrasound Biopsy Market Report:
Europe grows from $0.32 Billion in 2023 to $0.64 Billion in 2033. This progression reflects increasing uptake of minimally invasive diagnostics, investments in imaging technologies, and expanding procedural capabilities in hospital and diagnostic center settings.Asia Pacific Endobronchial Ultrasound Biopsy Market Report:
Asia Pacific grows from $0.25 Billion in 2023 to $0.5 Billion in 2033. Growth is supported by rising awareness of early lung cancer detection, expanding healthcare infrastructure, and greater availability of EBUS systems and consumables in clinical facilities.North America Endobronchial Ultrasound Biopsy Market Report:
North America is largest regional market, rising from $0.4 Billion in 2023 to $0.78 Billion in 2033. Regional expansion is driven by high clinical adoption in hospitals and diagnostic centers, ongoing device innovation, and active participation from leading manufacturers that support clinician training and product distribution.South America Endobronchial Ultrasound Biopsy Market Report:
Latin America grows from $0.09 Billion in 2023 to $0.18 Billion in 2033. Market gains are linked to broader access to diagnostic services, gradual adoption of minimally invasive techniques, and incremental investments in medical devices and clinician training.Middle East & Africa Endobronchial Ultrasound Biopsy Market Report:
Middle East and Africa grows from $0.14 Billion in 2023 to $0.27 Billion in 2033. Drivers include improved healthcare spending, introduction of advanced diagnostic tools, and growing procedural adoption in tertiary hospitals and specialized centers.Tell us your focus area and get a customized research report.
Research Methodology
Endobronchial Ultrasound Biopsy Market Analysis By Technology
The EBUS technologies, particularly EBUS and EBUS needles, play a significant role in market dynamics. EBUS accounts for a major share, comprising 82.94% of the total market in 2023. The EBUS needle segment is also significant, representing 17.06% market share in the same year. Advancements in technology are expected to enhance diagnostic capabilities, further driving market growth.
Endobronchial Ultrasound Biopsy Market Analysis By Application
The primary application of EBUS is in the diagnosis of lung cancer, which holds an 82.94% market share in 2023. Other diagnostic evaluations contribute to the remaining share. The emphasis on early diagnosis and cancer screening is pushing the demand for EBUS in various applications, further diversifying its utilization in thoracic medicine.
Endobronchial Ultrasound Biopsy Market Analysis By End User
Hospitals, being the foremost end-users, hold a substantial share of 68.85% of the EBUS market as of 2023. Diagnostic centers and research institutes also play important roles. The increasing number of EBUS procedures in hospitals, coupled with enhanced investments in diagnostic centers for advanced technologies, is steering growth in this segment.
Endobronchial Ultrasound Biopsy Market Analysis By Region
Regional analysis reveals significant variations in market growth and adoption of EBUS techniques. North America leads in market share, driven by advanced healthcare systems. Europe shows steady growth driven by healthcare reforms, whereas the Asia Pacific region is catching up with increasing healthcare investment, indicating a promising future for EBUS technologies across regions.
Endobronchial Ultrasound Biopsy Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Endobronchial Ultrasound Biopsy Industry
Olympus Corporation:
A leader in medical technologies, Olympus has a vast portfolio including EBUS devices, contributing significantly to advancements in diagnostic procedures.Boston Scientific Corporation:
Known for its innovative minimally invasive medical devices, Boston Scientific plays a crucial role in the EBUS market through its advanced EBUS product offerings.Medtronic :
Medtronic's comprehensive range of EBUS solutions exemplifies its commitment to enhancing patient outcomes in respiratory diagnostics.Fujifilm Holdings Corporation:
Fujifilm is known for its high-quality imaging devices and has made significant strides in EBUS technology to improve diagnostic accuracy.Conmed Corporation:
Conmed specializes in surgical instruments and endoscopic devices, contributing to the innovation of EBUS technology.We're grateful to work with incredible clients.
FAQs
What is the market size in 2023?
The market size for 2023 is $1.20 Billion, as reported in the input data for the Endobronchial Ultrasound Biopsy market.
How big will the market be in 2033?
The market is projected to reach $2.36 Billion in 2033 according to the provided forecast figures for the 2023 to 2033 period.
What is CAGR for the forecast period?
The reported compound annual growth rate (CAGR) for 2023 to 2033 is 6.8% based on the supplied market projections.
Is there a single fastest Growing region in the Endobronchial Ultrasound Biopsy Market Report market?
No single fastest-growing region is stated for the Endobronchial Ultrasound Biopsy Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top players?
Top companies named in the input are Olympus Corporation, Boston Scientific Corporation, Medtronic, Fujifilm Holdings Corporation, and Conmed Corporation.
What applications drive demand for EBUS?
Primary applications include diagnosis of lung cancer and other diagnostic evaluations, which are central to clinical adoption and procedural use.
Who are the main end users of EBUS products?
Main end users specified are hospitals, diagnostic centers, and research institutes, which account for procedural and research deployment.
What are the primary technologies in this market?
The reported technology segments are Endobronchial Ultrasound (EBUS) systems and EBUS needles, forming the core device and consumable categories.
How is regional growth characterized?
Regional figures show expansion across all listed regions with specific start and end values; North America is the largest region per the input data.
What drives adoption in hospitals and centers?
Adoption is driven by minimally invasive diagnostic benefits, improved imaging and needle technologies, and increased clinician training and procedural uptake.